• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

MB Venture Capital Fund

edit

MB Venture Partners is a venture capital firm specializing in investments in all stages of development. The firm does not invest in healthcare services, healthcare IT, and AgBio opportunities. It prefers to invest in seed or early stage financing but select later- stage financing are also considered. The firm typically invests in life sciences sector including biotechnology and medical device companies with a focus on: product solutions for musculoskeletal diseases, products to alleviate human suffering, and molecular therapeutics. It seeks to invest in opportunities across the United States for musculoskeletal related investments and Southeast and Midwest regions for investments in biotechnology, medical devices companies, and non-musculoskeletal investments. MB Venture Partners was founded in 2001 and is based in Memphis, Tennessee.

Recent Milestones

edit

• 
  MB Venture Capital Fund invested in AxioMed Spine. (10/25/10)
  Posted 10/26/10 at 5:55pm via onbiovc.com
• 
  MB Venture Capital Fund invested in Anulex. (6/7/10)
  Posted 6/7/10 at 8:44pm via onbiovc.com
• 
  MB Venture Capital Fund invested in Onyvax. (5/8/06)
  Posted 4/22/10 at 4:31am via onyvax.com

Investments

Videos

Sources

1. MB Venture Partners Gathers $22M For New Biomed Fund (fis.dowjones.com) [edit]
2. **OnBioVC Post 1,000** AxioMed Spine Corp.: Series D $15M (onbiovc.com) [edit]
3. Anulex Technologies, Inc.: Series E $18.3M (onbiovc.com) [edit]
4. Onyvax Raises £8 Million to Advance Development of Prostate Cancer Vaccine (onyvax.com) [edit]